by University of Pittsburgh Credit: Pixabay/CC0 Public Domain A group of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a test to detect a novel marker of Alzheimer’s disease neurodegeneration in a blood sample. A study on their results was published today in Brain. The biomarker, called brain-derived tau, or BD-tau, outperforms...
Boosting levels of the neurotransmitter norepinephrine with atomoxetine, a repurposed ADHD medication, may be able to stall neurodegeneration in people with early signs of Alzheimer’s disease, a study conducted at Emory Brain Health Center suggests. The results were published in the journal Brain. Norepinephrine is a neurotransmitter produced mainly by the locus coerueus, part of the...
